Literature DB >> 15331876

Delayed occlusion after internal carotid artery dissection under heparin.

Jens P Dreier1, Frank Lurtzing, Melanie Kappmeier, Georg Bohner, Randolf Klingebiel, Stefanie Leistner, Karl M Einhaupl, Eva Schielke, José M Valdueza.   

Abstract

Internal carotid artery dissection (ICAD) is a frequent etiology of stroke in the young. Immediate anticoagulation with unfractionated heparin is the most frequent treatment. A theoretical side effect of unfractionated heparin is an increase in the intramural hematoma resulting in hemodynamic cerebral infarction. We studied 20 patients with ICAD. All patients were immediately treated with unfractionated heparin. Activated partial thromboplastin time (aPTT) ratios were measured twice daily. We prospectively monitored the course of ICAD with repeated ultrasound in hospital. Unexpectedly, delayed ICA occlusion was noted in 5 patients under treatment. One of these developed a watershed infarct. We then analyzed the aPTT ratios over the first 6 days after diagnosis. Patients with delayed occlusion had significantly higher aPTT ratios (2.6 +/- 0.4 vs. 2.0 +/- 0.5, p < 0.05). Within the limits of a partially retrospective design, our study seems to support the notion that unfractionated heparin can increase the intramural hematoma. Our findings further justify a randomized clinical trial to resolve the anticoagulant/antiplatelet debate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331876     DOI: 10.1159/000080355

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  3 in total

1.  Cervical artery dissection.

Authors:  Alex Abou-Chebl
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

2.  Non-atherosclerotic vascular disease in the young.

Authors:  Osvaldo Camilo; Larry B Goldstein
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  Why antiplatelet treatment in spontaneous internal carotid dissection?

Authors:  O Bajenaru; C Tiu; B Dorobat; F Antochi
Journal:  J Neural Transm (Vienna)       Date:  2012-12-11       Impact factor: 3.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.